Jessica Lan

MD Anderson Cancer Center, Houston, TX

Poster(s):

• W192 - Multi-omic Analysis Data from Phase 1 Clinical Trial of CAN-2409 + Valacyclovir in Combination with Nivolumab in High-grade Glioma Demonstrates Systemic Activity After Locally Delivered CAN-2409 Viral Immunotherapy
  Wednesday, June 21, 2023

  7:30 AM – 7:30 PM